{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:58Z","timestamp":1790370238515,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jcf.2026.09.009","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:35:29Z","timestamp":1790368529000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterozygous CFTR variants associated with low-phospholipid-associated cholelithiasis phenotypes expand hepatobiliary disorders spectrum"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0645-2374","authenticated-orcid":false,"given":"Camille","family":"Giannetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Carmarans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Gerolami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Borentain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solene","family":"Hoibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9024-310X","authenticated-orcid":false,"given":"Catherine","family":"Badens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Buffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0001","article-title":"Low-phospholipid-associated cholelithiasis syndrome: prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2021","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.009_bib0002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jviscsurg.2019.02.006","article-title":"Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: a synthetic review","volume":"156","author":"Goubault","year":"2019","journal-title":"J Visc Surg"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.009_bib0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","article-title":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","volume":"73","author":"St\u00e4ttermayer","year":"2020","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.009_bib0004","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ejhg.2011.186","article-title":"First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis","volume":"20","author":"Pasmant","year":"2012","journal-title":"Eur J Hum Genet EJHG"},{"issue":"3","key":"10.1016\/j.jcf.2026.09.009_bib0005","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jcf.2026.09.009_bib0006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0007","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2021.09.042","article-title":"Cystic fibrosis-related liver disease: clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies","volume":"76","author":"Dana","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcf.2026.09.009_bib0008","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcf.2017.07.006","article-title":"Gallbladder and bile duct disease in Cystic Fibrosis","volume":"16","author":"Assis","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.009_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000324687","article-title":"Oude Elferink RP, Beuers U. Biliary bicarbonate secretion constitutes a protective mechanism against bile acid-induced injury in man","volume":"29","author":"Hohenester","year":"2011","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.009_bib0010","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO3\u2212 umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jcf.2026.09.009_bib0011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199809033391001","article-title":"Mutations of the cystic fibrosis gene in patients with chronic pancreatitis","volume":"339","author":"Sharer","year":"1998","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0012","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/hep.28929","article-title":"Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor (VX-770)","volume":"65","author":"Delaunay","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0013","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3390\/ijms24021236","article-title":"Ivacaftor-mediated potentiation of ABCB4 missense mutations affecting critical motifs of the NBDs: repositioning perspectives for hepatobiliary diseases","volume":"24","author":"Delaunay","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.jcf.2026.09.009_bib0014","first-page":"1320","article-title":"Clinical experience with carrier screening in a general population: support for a comprehensive pan-ethnic approach","volume":"22","author":"Westemeyer","year":"2020","journal-title":"Genet Med J Am Coll Med Genet"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.sagf.2024.12.006","article-title":"Vingt ans de d\u00e9pistage n\u00e9onatal de la mucoviscidose","volume":"24","author":"Br\u00e9geaut","year":"2025","journal-title":"Sages-Femmes"},{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0016","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/gim.2014.113","article-title":"Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy","volume":"17","author":"Audr\u00e9zet","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.jcf.2026.09.009_bib0017","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1086\/302928","article-title":"High frequency of cystic Fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia","volume":"66","author":"Lira","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.jcf.2026.09.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276397","article-title":"Bicarbonate defective CFTR variants increase risk for chronic pancreatitis: a meta-analysis","volume":"17","author":"Berke","year":"2022","journal-title":"PLOS One"},{"issue":"4","key":"10.1016\/j.jcf.2026.09.009_bib0019","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jcf.2024.03.008","article-title":"ECFS standards of care on CFTR-related disorders: identification and care of the disorders","volume":"23","author":"Simmonds","year":"2024","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2026.09.009_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/rr82","article-title":"CFTR-opathies\u2019: disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations","volume":"2","author":"Noone","year":"2001","journal-title":"Respir Res"},{"key":"10.1016\/j.jcf.2026.09.009_bib0021","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.09.009_bib0022","unstructured":"Cystic fibrosis carriers are at increased risk for a wide range of cystic fibrosis-related conditions | PNAS [Internet]. [cited 2026 Jun 23]. Available from: https:\/\/www.pnas.org\/doi\/10.1073\/pnas.1914912117."},{"issue":"2","key":"10.1016\/j.jcf.2026.09.009_bib0023","article-title":"Elexacaftor\u2013tezacaftor\u2013ivacaftor and cystic fibrosis liver disease: a turning point that calls for cautious optimism","volume":"8","author":"Rautou","year":"2026","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.jcf.2026.09.009_bib0024","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/diagnostics16050726","article-title":"Beyond the pump: the evolving molecular landscape of intrahepatic cholestasis","volume":"16","author":"Ziccardi","year":"2026","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jcf.2026.09.009_bib0025","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v18.i1.113485","article-title":"Clinical spectrum and genotype-phenotype correlation of ABCB4 mutations in children: insights from a North Indian cohort","volume":"18","author":"Thunga","year":"2026","journal-title":"World J Hepatol"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326037422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:35:33Z","timestamp":1790368533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326037422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S1569199326037422"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.009","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterozygous CFTR variants associated with low-phospholipid-associated cholelithiasis phenotypes expand hepatobiliary disorders spectrum","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}